Treace Medical Concepts (TMCI) Competitors $6.72 -0.26 (-3.72%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TMCI vs. LMAT, WRBY, CNMD, TNDM, LQDA, KMTS, CDRE, BLFS, PLSE, and FNAShould you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include LeMaitre Vascular (LMAT), Warby Parker (WRBY), CONMED (CNMD), Tandem Diabetes Care (TNDM), Liquidia (LQDA), Kestra Medical Technologies (KMTS), Cadre (CDRE), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), and Paragon 28 (FNA). These companies are all part of the "medical equipment" industry. Treace Medical Concepts vs. LeMaitre Vascular Warby Parker CONMED Tandem Diabetes Care Liquidia Kestra Medical Technologies Cadre BioLife Solutions Pulse Biosciences Paragon 28 LeMaitre Vascular (NASDAQ:LMAT) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, community ranking, dividends, media sentiment, institutional ownership, analyst recommendations and profitability. Which has stronger earnings & valuation, LMAT or TMCI? LeMaitre Vascular has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLeMaitre Vascular$226.26M8.29$30.10M$1.9841.92Treace Medical Concepts$210.82M2.00-$49.53M-$0.85-7.91 Do insiders & institutionals believe in LMAT or TMCI? 84.6% of LeMaitre Vascular shares are owned by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are owned by institutional investors. 10.8% of LeMaitre Vascular shares are owned by insiders. Comparatively, 27.7% of Treace Medical Concepts shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Do analysts rate LMAT or TMCI? LeMaitre Vascular currently has a consensus target price of $98.14, indicating a potential upside of 18.24%. Treace Medical Concepts has a consensus target price of $10.16, indicating a potential upside of 51.15%. Given Treace Medical Concepts' higher probable upside, analysts clearly believe Treace Medical Concepts is more favorable than LeMaitre Vascular.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LeMaitre Vascular 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.63Treace Medical Concepts 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29 Does the media favor LMAT or TMCI? In the previous week, Treace Medical Concepts had 27 more articles in the media than LeMaitre Vascular. MarketBeat recorded 32 mentions for Treace Medical Concepts and 5 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.16 beat Treace Medical Concepts' score of 0.12 indicating that LeMaitre Vascular is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LeMaitre Vascular 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Treace Medical Concepts 3 Very Positive mention(s) 2 Positive mention(s) 19 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral Is LMAT or TMCI more profitable? LeMaitre Vascular has a net margin of 19.40% compared to Treace Medical Concepts' net margin of -30.33%. LeMaitre Vascular's return on equity of 13.15% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets LeMaitre Vascular19.40% 13.15% 11.47% Treace Medical Concepts -30.33%-51.12%-26.36% Which has more risk & volatility, LMAT or TMCI? LeMaitre Vascular has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Does the MarketBeat Community believe in LMAT or TMCI? LeMaitre Vascular received 489 more outperform votes than Treace Medical Concepts when rated by MarketBeat users. Likewise, 70.45% of users gave LeMaitre Vascular an outperform vote while only 44.07% of users gave Treace Medical Concepts an outperform vote. CompanyUnderperformOutperformLeMaitre VascularOutperform Votes51570.45% Underperform Votes21629.55% Treace Medical ConceptsOutperform Votes2644.07% Underperform Votes3355.93% SummaryLeMaitre Vascular beats Treace Medical Concepts on 16 of the 19 factors compared between the two stocks. Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMCI vs. The Competition Export to ExcelMetricTreace Medical ConceptsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$422.62M$4.40B$5.23B$8.47BDividend YieldN/A37.68%4.99%4.19%P/E Ratio-6.7930.2026.5619.71Price / Sales2.0053.23398.74120.61Price / CashN/A51.0838.3134.62Price / Book3.006.186.684.51Net Income-$49.53M$67.09M$3.22B$247.94M7 Day Performance-6.67%2.16%1.09%5.23%1 Month Performance-0.59%5.73%5.82%11.44%1 Year PerformanceN/A21.48%13.73%6.24% Treace Medical Concepts Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMCITreace Medical Concepts2.6123 of 5 stars$6.72-3.7%$10.16+51.1%+54.1%$422.62M$210.82M-6.79250Earnings ReportGap UpLMATLeMaitre Vascular3.1188 of 5 stars$80.44+2.2%$98.14+22.0%+9.3%$1.82B$219.86M43.96490Positive NewsHigh Trading VolumeWRBYWarby Parker3.7021 of 5 stars$16.96+0.3%$22.64+33.5%+19.4%$1.77B$771.32M-62.813,030Analyst ForecastCNMDCONMED4.1641 of 5 stars$56.94-1.3%$62.20+9.2%-17.5%$1.76B$1.32B13.434,100Positive NewsTNDMTandem Diabetes Care4.7562 of 5 stars$21.29-0.9%$39.81+87.0%-47.3%$1.42B$940.20M-11.032,600LQDALiquidia2.5915 of 5 stars$16.12+1.8%$26.88+66.7%+31.7%$1.38B$14.00M-9.8950Earnings ReportAnalyst ForecastPositive NewsKMTSKestra Medical TechnologiesN/A$22.57-5.0%$27.50+21.8%N/A$1.22B$52.64M0.00300News CoverageCDRECadre2.6088 of 5 stars$29.85+0.4%$37.00+24.0%+20.6%$1.21B$567.56M35.962,240Analyst RevisionBLFSBioLife Solutions2.4478 of 5 stars$24.20-4.2%$31.17+28.8%+11.8%$1.15B$82.25M-22.83440Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsPLSEPulse Biosciences0.8716 of 5 stars$16.59-3.5%N/A+135.5%$1.12B$700,000.000.00140Earnings ReportNews CoverageFNAParagon 281.0166 of 5 stars$13.11+0.1%$14.20+8.4%+61.6%$1.10B$256.18M-17.71343,000High Trading Volume Related Companies and Tools Related Companies LeMaitre Vascular Alternatives Warby Parker Alternatives CONMED Alternatives Tandem Diabetes Care Alternatives Liquidia Alternatives Kestra Medical Technologies Alternatives Cadre Alternatives BioLife Solutions Alternatives Pulse Biosciences Alternatives Paragon 28 Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TMCI) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredCan This System Really Predict Stocks to the Day?Imagine foreseeing a 30% stock jump — to the day — weeks before it happens. Introducing a new way to predict t...InvestorPlace | Sponsored“America is running out of power” - The Washington PostAccording to The Washington Post, AI is causing America to “run out of power”... It’s true — utility compan...True Market Insiders | SponsoredTrump Made a Deal. Your Retirement Could Still Be in Danger.America is still barreling toward a financial cliff. This isn't political. It's mathematical. And no trade ...Lear Capital | SponsoredBITCOIN Liquidity pools are the backbone of crypto—and right now, they’re exploding with activity. By providing liqui...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TMCI Stock Free TMCI Stock Alerts